Related Concepts
Related Feeds
AML: Role of LSD1 by CRISPR (Keystone)
Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.
Acute Myeloid Leukemia
Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.
Related Papers
Oncology Letters
Bo-Tao Ning, Yong-Min Tang
Zhongguo shi yan xue ye xue za zhi
Hao-Bo Huang, Rong Zhan
Zhongguo shi yan xue ye xue za zhi
Li-Xing YanJi He
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Wei-Jia WangDong-Mei Wen
Zhongguo shi yan xue ye xue za zhi
Chao LyuKai-Lin Xu